BioRem Inc. (BRM.V)
| Previous Close | 1.9900 |
| Open | 1.9700 |
| Bid | 1.9800 x 0 |
| Ask | 2.0000 x 0 |
| Day's Range | 1.9700 - 1.9900 |
| 52 Week Range | 0.8100 - 2.0800 |
| Volume | |
| Avg. Volume | 25,711 |
| Market Cap | 31.081M |
| Beta (5Y Monthly) | 0.89 |
| PE Ratio (TTM) | 15.23 |
| EPS (TTM) | 0.1300 |
| Earnings Date | May 22, 2024 - May 27, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- ACCESSWIRE
Keynotes, Educational Panels and 96 Companies to Present at the Planet MicroCap Showcase: VEGAS on April 30 - May 2, 2024 at the Paris Hotel & Casino in Las Vegas, NV
LAS VEGAS, NV / ACCESSWIRE / April 29, 2024 / Planet MicroCap presents the Planet MicroCap Showcase: VEGAS taking place on April 30 - May 2, 2024, where 96 MicroCap public and private companies will be presenting at the Paris Hotel & Casino in Las ...
CNW GroupBiorem Reports 2023 Financial Results including $0.14 earnings per share
BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced its results for the three and twelve-month periods ended December 31, 2023. Biorem's complete fiscal 2023 year-end financial statements and MD&A have been filed on SEDAR (www.sedar.com).
- CNW Group
Biorem Reports Third Quarter Results, Record Order Backlog and Quarterly EPS of $0.03
BIOREM Inc. (TSXV: BRM) ("BIOREM" or "The Company") today announced its results for the three and nine-month periods ended September 30, 2023. BIOREM's complete second quarter financial statements and MD&A have been filed on SEDAR (www.sedar.com).
